Avesi Partners-backed Danforth Health acquires rare disease consultancy Ambit

Published on September 11, 2026

Ambit RD, founded to help biopharma companies navigate commercial challenges in rare and specialty disease markets, brings AI-powered patient identification and analytics tools to Danforth's platform.

The post Avesi Partners-backed Danforth Health acquires rare disease consultancy Ambit appeared first on PE Hub.